cCAM Biotherapeutics has received approval form the US Food and Drug Administration to commence a Phase 1 trial for CM-24, a first-in-class immunomodulatory monoclonal antibody (mAb) for the treatment of various types of cancers. The study is expected to commence during the first quarter of 2015. CM-24 is directed against...
Read more
Monthly Archives: January 2015
Surgical Theater Finalist in Digital Health
Surgical Theater has been nominated as a finalist in the 2015 Everyday Health Awards for innovation in digital health and wellness solutions. The company was founded by former Israeli Air Force officers Alon Geri and Moty Avisar in 2010, developed a revolutionary brain surgery simulation method for doctors. Much like...
Read more
BiondVax to Raise $10 M on NASDAQ
BiondVax Pharmaceuticals Ltd. (TASE:BNDX), which is developing a universal vaccine for many types of influenza, announced that it was submitting a prospectus to Nasdaq that will allow it to offer shares through American depositary receipts (ADRs) after the company is listed. BiondVax is seeking to raise up to $10 million...
Read more
NeuroDerm Parkinson’s Success
NeuroDerm Ltd. (NASDAQ: NDRM), a clinical-stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, announced that continuous, subcutaneous delivery of the company’s proprietary liquid levodopa/carbidopa (LD/CD) product candidates, ND0612H and ND0612L, led to clinically-significant plasma levodopa levels. These results suggest that the high dose version, ND0612H, intended for...
Read more